These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 9546780)

  • 21. Chemoprevention strategies using NSAIDs and COX-2 inhibitors.
    Keller JJ; Giardiello FM
    Cancer Biol Ther; 2003; 2(4 Suppl 1):S140-9. PubMed ID: 14508092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Considerations in the use of COX-2 inhibitors in spinal fusion surgery.
    Matsumura J
    Anesth Analg; 2001 Sep; 93(3):803-4. PubMed ID: 11524365
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of cyclooxygenase-2 in the angiogenesis of colorectal cancer.
    Rao M; Yang W; Seifalian AM; Winslet MC
    Int J Colorectal Dis; 2004 Jan; 19(1):1-11. PubMed ID: 12783255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-steroidal anti-inflammatory and cyclooxygenase-2-selective inhibitors in clinical cancer prevention trials.
    Hawk ET; Viner JL; Umar A
    Prog Exp Tumor Res; 2003; 37():210-42. PubMed ID: 12795057
    [No Abstract]   [Full Text] [Related]  

  • 25. [The cardiovascular safety of cyclooxygenase-2 (COX-2) inhibitors].
    Hasdai D; Gottlieb S; Godbourt U; Hod H; Kaluski E
    Harefuah; 2002 Oct; 141(10):922-4. PubMed ID: 12420602
    [No Abstract]   [Full Text] [Related]  

  • 26. Nonsteroidal anti-inflammatory drugs and Alzheimer disease: what's next?
    Launer LJ
    JAMA; 2003 Jun; 289(21):2865-7. PubMed ID: 12783919
    [No Abstract]   [Full Text] [Related]  

  • 27. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
    In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclooxygenase-2: a potential target in breast cancer.
    Wang D; Dubois RN
    Semin Oncol; 2004 Feb; 31(1 Suppl 3):64-73. PubMed ID: 15052544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is there a place for non-selective NSAIDs in the treatment of arthritis?
    Crofford LJ
    Joint Bone Spine; 2002 Jan; 69(1):4-7. PubMed ID: 11858355
    [No Abstract]   [Full Text] [Related]  

  • 30. Strategies to safely interfere with prostanoid activity while avoiding adverse renal effects: could COX-2 and COX-LOX dual inhibition be the answer?
    Gambaro G
    Nephrol Dial Transplant; 2002 Jul; 17(7):1159-62. PubMed ID: 12105234
    [No Abstract]   [Full Text] [Related]  

  • 31. COX-2: a target for prevention and treatment of esophageal cancer.
    Altorki N
    J Surg Res; 2004 Mar; 117(1):114-20. PubMed ID: 15013721
    [No Abstract]   [Full Text] [Related]  

  • 32. Controversies in COX-2 inhibitor therapy: closing remarks.
    Abramson SB; Furst DE; Hochberg MC; Patrono C
    Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S77-80. PubMed ID: 11695257
    [No Abstract]   [Full Text] [Related]  

  • 33. COX-2 inhibitors: a review.
    Houston AM; Teach SJ
    Pediatr Emerg Care; 2004 Jun; 20(6):396-9; quiz 400-2. PubMed ID: 15179150
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-inflammatories for cardiovascular disease.
    Masferrer JL; Needleman P
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12400-1. PubMed ID: 11058172
    [No Abstract]   [Full Text] [Related]  

  • 35. Arthritis drug approved for polyp prevention blazes trail for other prevention trials.
    Smigel K
    J Natl Cancer Inst; 2000 Feb; 92(4):297-9. PubMed ID: 10675374
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanisms underlying chemoprevention of ovarian cancer.
    Mills GB
    Clin Cancer Res; 2002 Jan; 8(1):7-10. PubMed ID: 11801533
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of cyclooxygenase inhibitors in cancer prevention.
    Anderson WF; Umar A; Viner JL; Hawk ET
    Curr Pharm Des; 2002; 8(12):1035-62. PubMed ID: 11945150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Basic therapy for rheumatoid arthritis: nonsteroidal anti-inflammatory drugs.
    Daoud KF; Jackson CG; Williams HJ
    Compr Ther; 1999; 25(8-10):427-33. PubMed ID: 10520445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptosis induction and cyclooxygenase-2 regulation in human colorectal adenoma and carcinoma cell lines by the cyclooxygenase-2-selective non-steroidal anti-inflammatory drug NS-398.
    Elder DJ; Halton DE; Crew TE; Paraskeva C
    Int J Cancer; 2000 May; 86(4):553-60. PubMed ID: 10797271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevention of colorectal cancer: acetylsalicyclic acid and cyclo-oxygenase-2 inhibitors are only partially effective].
    Kleibeuker JH; de Vries EG
    Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2203-7. PubMed ID: 14640056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.